Abbott Laboratories

• 

  SEC, FINRA, DOL Enforcement Roundup: Investing Website Exposed as $600M Scam

  By Marlene Y. Satter, AdvisorOne  |  August 23, 2012

  A CEO who fed inside tips to a pro baseball player and an investment website running a $600 million Ponzi scheme were among those charged by the SEC recently.

• 

  Research Roundtable: Gundlach, Rodriguez, Others

  By Jane Wollman Rusoff  |  November 23, 2011

  Our expert panel — John Buckingham, Kenneth L. Fisher, Jeffrey Gundlach, Robert Rodriguez — sees turbulence and opportunity in the year ahead, as history makes clear that presidential election years are usually favorable for the securities markets.

• 

  Top 8 Most Overpaid CEOs of Public Companies

  By Marlene Y. Satter, AdvisorOne  |  November 2, 2011

  Some CEOs keep raking in the bucks even as the companies they lead lose market share, see their stock price fall, or both.

• Liu-Er Chen of Evergreen Health Care Fund

  By Staff Writer  |  August 25, 2003

  S&P Rank: 4 Stars Aug. 14, 2003 On the Cusp of a New Drug Boom Quick Take: Drug and biotech stocks suffered in 2002, hurt by poor earnings,...

• Robert Torray and Douglas Eby of Torray Fund

  By Staff Writer  |  May 6, 2002

  S&P Rank: Four Stars